• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性血清chemerin与钙、碱性磷酸酶及骨密度的相关性

Association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal females.

作者信息

Tariq Saba, Tariq Sundus, Shahzad Muhammad

机构信息

Saba Tariq, MBBS, M.Phil. Associate Professor, Pharmacology, University Medical & Dental College, Faisalabad-38000, Pakistan. PhD Research Scholar, Pharmacology, University of Health Sciences, Lahore, Pakistan.

Sundus Tariq, MBBS, M.Phil. Associate Professor, Physiology, University Medical & Dental College, Faisalabad-38000, Pakistan. PhD Research Scholar, Physiology, University of Health Sciences, Lahore, Pakistan.

出版信息

Pak J Med Sci. 2021 Mar-Apr;37(2):384-388. doi: 10.12669/pjms.37.2.3907.

DOI:10.12669/pjms.37.2.3907
PMID:33679918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7931311/
Abstract

OBJECTIVES

To investigate the association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal non-osteoporotic and osteoporotic females.

METHODS

This cross-section analysis was carried out at the orthopedic department of Madina Teaching Hospital, Faisalabad, Pakistan, in the year 2017-2019. Postmenopausal females were divided into two groups according to their bone mineral density (BMD). All osteoporotic females had a T-score of -2.5 or less. Data were analyzed on SPSS-24.

RESULTS

A total of 140 women were included in our study (80 osteoporotic and 60 non-osteoporotic). Non significant difference in age and BMI was observed between osteoporotic and non-osteoporotic subjects (p=0.152) and (p=0.291) respectively. There was a significant difference found in total BMD, serum chemerin levels between osteoporotic and non-osteoporotic subjects p<0.001 in both parameters. No significant correlation of serum chemerin was found with serum calcium, serum alkaline phosphatase and BMD in postmenopausal osteoporotic females (p=0.907), (p=0.318) (p=0.664) respectively. A significant negative correlation was found between serum alkaline phosphatase levels and total BMD in postmenopausal osteoporotic females (p=- 0.039). Linear regression analysis of serum alkaline phosphatase levels with total BMD showed no association between BMD and serum alkaline phosphatase levels (p=0.869).

CONCLUSION

There is no association of serum chemerin with calcium, ALP and bone mineral density in non-osteoporotic and osteoporotic postmenopausal females.

摘要

目的

探讨绝经后非骨质疏松和骨质疏松女性血清chemerin与钙、碱性磷酸酶及骨密度的关系。

方法

本横断面分析于2017 - 2019年在巴基斯坦费萨拉巴德麦地那教学医院骨科进行。绝经后女性根据骨密度(BMD)分为两组。所有骨质疏松女性的T值均为-2.5或更低。数据在SPSS - 24软件上进行分析。

结果

本研究共纳入140名女性(80名骨质疏松患者和60名非骨质疏松患者)。骨质疏松组和非骨质疏松组在年龄和体重指数方面无显著差异,分别为(p = 0.152)和(p = 0.291)。骨质疏松组和非骨质疏松组在总骨密度、血清chemerin水平方面存在显著差异,两个参数的p值均<0.001。绝经后骨质疏松女性血清chemerin与血清钙、血清碱性磷酸酶及骨密度之间未发现显著相关性,分别为(p = 0.907)、(p = 0.318)、(p = 0.664)。绝经后骨质疏松女性血清碱性磷酸酶水平与总骨密度之间存在显著负相关(p = -0.039)。血清碱性磷酸酶水平与总骨密度的线性回归分析显示骨密度与血清碱性磷酸酶水平之间无关联(p = 0.869)。

结论

绝经后非骨质疏松和骨质疏松女性血清chemerin与钙、碱性磷酸酶及骨密度之间无关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4e/7931311/51921c78fafa/PJMS-37-384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4e/7931311/1cc102b6ce96/PJMS-37-384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4e/7931311/51921c78fafa/PJMS-37-384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4e/7931311/1cc102b6ce96/PJMS-37-384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4e/7931311/51921c78fafa/PJMS-37-384-g002.jpg

相似文献

1
Association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal females.绝经后女性血清chemerin与钙、碱性磷酸酶及骨密度的相关性
Pak J Med Sci. 2021 Mar-Apr;37(2):384-388. doi: 10.12669/pjms.37.2.3907.
2
Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females.碱性磷酸酶是绝经后女性骨密度的一个预测指标。
Pak J Med Sci. 2019;35(3):749-753. doi: 10.12669/pjms.35.3.188.
3
Serum tumour necrosis factor alpha in osteopenic and osteoporotic postmenopausal females: A cross-sectional study in Pakistan.骨质疏松和骨质减少的绝经后女性血清肿瘤坏死因子α:巴基斯坦的一项横断面研究。
J Pak Med Assoc. 2018 Mar;68(3):428-431.
4
Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health.绝经后女性骨健康改变与维生素 D 和抵抗素的关系。
Front Endocrinol (Lausanne). 2021 Jan 15;11:615440. doi: 10.3389/fendo.2020.615440. eCollection 2020.
5
Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females.伊班膦酸钠治疗对绝经后骨质疏松女性血清趋化素、内脏脂肪素、网膜素-1和骨保护素(OPG)的影响
Front Pharmacol. 2022 Feb 9;13:822671. doi: 10.3389/fphar.2022.822671. eCollection 2022.
6
Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females.血清内脏脂肪素、肠三叶因子和 RARRES2 及其遗传变异与绝经后女性骨密度的关系。
Front Endocrinol (Lausanne). 2022 Nov 30;13:1024860. doi: 10.3389/fendo.2022.1024860. eCollection 2022.
7
Association of High Serum Chemerin with Bone Mineral Density Loss and Osteoporotic Fracture in Elderly Chinese Women.高血清chemerin水平与中国老年女性骨密度降低及骨质疏松性骨折的关联
Int J Womens Health. 2022 Feb 2;14:107-118. doi: 10.2147/IJWH.S337985. eCollection 2022.
8
[Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].[随机测量24小时尿钙排泄量和血清总碱性磷酸酶在绝经后骨质疏松症女性骨折风险测定中是否有作用?]
Rev Med Chir Soc Med Nat Iasi. 2006 Apr-Jun;110(2):291-4.
9
Relationship of anthropometric measures with bone mineral density in postmenopausal non-osteoporotic, osteopenic and osteoporotic women.绝经后非骨质疏松、骨质减少和骨质疏松女性的人体测量指标与骨密度的关系。
J Pak Med Assoc. 2017 Apr;67(4):590-594.
10
Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.绝经后骨质疏松女性血清骨钙素和肽 C 的估算。
Osteoporos Int. 2010 May;21(5):751-5. doi: 10.1007/s00198-009-1001-3. Epub 2009 Jul 14.

引用本文的文献

1
Bridging the Gap: A narrative review of osteoporosis disability, adipokines, and the role of AI in postmenopausal women.弥合差距:关于骨质疏松症残疾、脂肪因子以及人工智能在绝经后女性中的作用的叙述性综述
Pak J Med Sci. 2024 Aug;40(7):1572-1577. doi: 10.12669/pjms.40.7.9072.
2
Editorial: Osteoporosis and adipokines: the potential for future treatment.社论:骨质疏松症与脂肪因子:未来治疗的潜力
Front Endocrinol (Lausanne). 2024 Apr 10;15:1405412. doi: 10.3389/fendo.2024.1405412. eCollection 2024.
3
A diagnostic approach integrated multimodal radiomics with machine learning models based on lumbar spine CT and X-ray for osteoporosis.

本文引用的文献

1
Serum resistin levels as predictor of low bone mineral density in postmenopausal women.绝经后妇女血清抵抗素水平与低骨密度的关系。
Health Care Women Int. 2021 Jan;42(1):82-91. doi: 10.1080/07399332.2020.1798965. Epub 2020 Aug 3.
2
Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.趋化素治疗抑制乳腺癌细胞的生长和骨侵袭。
Int J Mol Sci. 2020 Apr 20;21(8):2871. doi: 10.3390/ijms21082871.
3
Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis.循环中趋化素和脂联素浓度与肝脂肪变性的关联。
基于腰椎 CT 和 X 射线的多模态放射组学与机器学习模型相结合的骨质疏松症诊断方法。
J Bone Miner Metab. 2023 Nov;41(6):877-889. doi: 10.1007/s00774-023-01469-0. Epub 2023 Oct 28.
4
Application of bone alkaline phosphatase and 25-oxhydryl-vitamin D in diagnosis and prediction of osteoporotic vertebral compression fractures.骨碱性磷酸酶和 25-羟维生素 D 在骨质疏松性椎体压缩骨折诊断和预测中的应用。
J Orthop Surg Res. 2023 Sep 30;18(1):739. doi: 10.1186/s13018-023-04144-2.
5
Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females.血清内脏脂肪素、肠三叶因子和 RARRES2 及其遗传变异与绝经后女性骨密度的关系。
Front Endocrinol (Lausanne). 2022 Nov 30;13:1024860. doi: 10.3389/fendo.2022.1024860. eCollection 2022.
6
The correlation between serum total alkaline phosphatase and bone mineral density in young adults.年轻人血清总碱性磷酸酶与骨密度的相关性。
BMC Musculoskelet Disord. 2022 May 18;23(1):467. doi: 10.1186/s12891-022-05438-y.
Endocr Connect. 2019 Aug 1;8(8):1097-1107. doi: 10.1530/EC-19-0300.
4
Status of bone health and association of socio-demographic characteristics with Bone Mineral Density in Pakistani Females.巴基斯坦女性的骨骼健康状况以及社会人口学特征与骨矿物质密度的关联
Pak J Med Sci. 2019;35(3):812-817. doi: 10.12669/pjms.35.3.551.
5
Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females.碱性磷酸酶是绝经后女性骨密度的一个预测指标。
Pak J Med Sci. 2019;35(3):749-753. doi: 10.12669/pjms.35.3.188.
6
Changes in pro-inflammatory cytokines and antimicrobial proteins in elderly women with iron deficiency anemia.缺铁性贫血老年女性促炎细胞因子和抗菌蛋白的变化
Pak J Med Sci. 2019 Mar-Apr;35(2):298-301. doi: 10.12669/pjms.35.2.520.
7
International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin) and GPR1 (Chemerin) Nomenclature, Pharmacology, and Function.国际基础与临床药理学联合会CIII:凯莫瑞受体CMKLR1(凯莫瑞)和GPR1(凯莫瑞)命名、药理学及功能
Pharmacol Rev. 2018 Jan;70(1):174-196. doi: 10.1124/pr.116.013177. Epub 2017 Dec 26.
8
Association of serum leptin with bone mineral density in postmenopausal osteoporotic females.绝经后骨质疏松女性血清瘦素与骨密度的关系
Gynecol Endocrinol. 2017 Apr;33(4):287-291. doi: 10.1080/09513590.2016.1261103. Epub 2016 Dec 23.
9
Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation.趋化因子样受体1是一种新型的Wnt靶基因,可调节间充质干细胞分化。
Stem Cells. 2017 Mar;35(3):711-724. doi: 10.1002/stem.2520. Epub 2016 Nov 11.
10
Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels.绝经后骨质疏松症与血清趋化素和鸢尾素有关,但与载脂蛋白M水平无关。
J Menopausal Med. 2016 Aug;22(2):76-9. doi: 10.6118/jmm.2016.22.2.76. Epub 2016 Aug 30.